Posted , 2 users are following.
You may already be aware of the recent news cautions on this COPD medicine.
For those who are not yet aware the caution is with the Spiriva Respimat mist inhaler concerning patients with existing cardiac problems. [i:152f3db3dd](See Pulse News quote below) [/i:152f3db3dd]
Do speak with your doc if you take this medicine so you can personally, be properly guided by a medical professional.
To quote in brief from various sources........
[b:152f3db3dd]Yahoo News dated 14 June 2011:[/b:152f3db3dd]
[i:152f3db3dd]\"The new study, published in the British Medical Journal, is based on an analysis of data from five clinical trials involving 6,500 people\"[/i:152f3db3dd]
[b:152f3db3dd]Patient UK news item dated 15 June 2011:[/b:152f3db3dd]
[i:152f3db3dd]\"What we think is going on is that the mist inhaler is delivering a higher concentration of tiotropium than it should be\"[/i:152f3db3dd]
[b:152f3db3dd]From Pulse news dated 14 June 2011:[/b:152f3db3dd]
'Tiotropium remains a very effective drug in the management of COPD, but it may be wise to consider using the dry powdered form of the drug rather than the respimat in patients with pre-existing heart problems until further data becomes available.'
[i:152f3db3dd][b:152f3db3dd]Tiotropium [/b:152f3db3dd]= Spiriva medicine[/i:152f3db3dd]
[i:152f3db3dd][b:152f3db3dd]Respimat [/b:152f3db3dd]= The Spiriva Respimat Mist inhaler.[/i:152f3db3dd]
different delivery from:
The [b:152f3db3dd]dry powdered form [/b:152f3db3dd]which is capsule used in the Spiriva handihaler.[/i:152f3db3dd]
1 like, 7 replies